Published in the November edition of PharmaTimes – We’re all getting older but what can we do to halt its wicked ways? Old age. It’s something we all have in common. We either are old or, with a certain amount of fortune, we will experience it at some stage in the future. But with old age, comes trepidation.
Published in Drug Discovery & Development – Endometriosis is a chronic incurable gynecological condition with cyclical pelvic pain, heavy bleeding, infertility, and reduced quality of life as its main manifestations. Almost half of women with it experience infertility. [1] No symptoms are specifically pathognomonic or characteristic of endometriosis. Often referred to as a ‘silent disease’ because of how often the diagnosis is missed, delayed, or dismissed, the rapid upward incidence of endometriosis since the 1980s has also led to the use of the term “silent epidemic”. [2] Approximately 10 percent of reproductive age women, or 190 million globally are impacted by it, which is no small number.
YouTube video interviews with Dr. Lucy Kennedy from Cleveland Clinic Development of AdAPT-001, a novel TGF-β-trap-enhanced oncolytic virus Phase I/II trial of AdAPT-001, an oncolytic virus, and a checkpoint inhibitor in solid tumors The future of AdAPT-001 in patients...
What do dictators and the military have in common with tumors and stroma? The answer: symbiosis – a relationship in which two different types closely and intimately interact with each other to the benefit of at least one of the types. The famous phrase, “no man is an...
EpicentRx used its AdAPT Platform to develop a nucleocapsid-based next-gen COVID 19 vaccine candidate and is ready for clinical trials. CEO Dr. Tony Reid recently discussed with Drug Discovery & Development.
BioSpace
BioSpace
Genetic Engineering and Biotechnology News